MacroGenics
MGNX
#8434
Rank
C$0.38 B
Marketcap
C$6.05
Share price
-5.40%
Change (1 day)
202.66%
Change (1 year)

Operating Margin for MacroGenics (MGNX)

Operating Margin as of July 2026 (TTM): -45.21%

According to MacroGenics's latest financial reports and stock price the company's current Operating Margin is -45.21%. At the end of 2025 the company had an Operating Margin of -44.67%.

Operating Margin history for MacroGenics from 2013 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-44.67%3.21%
2024-43.28%233.35%
2023-12.98%-83.74%
2022-79.83%-70.12%
2021-267.20%99.31%
2020-134.06%-53.07%
2019-285.67%-2.15%
2018-291.94%1950.38%
2017-14.24%-79.47%
2016-69.35%241.44%
2015-20.31%-74.95%
2014-81.07%-12670.31%
20130.64%-95.31%
201213.76%23.3%
201111.16%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.01%-126.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
43.07%-195.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
24.41%-153.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
36.07%-179.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
32.40%-171.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
19.79%-143.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-174.61% 286.22%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.